siRNA treatment lowers triglycerides in patients with rare disorder

.RESEARCH STUDY HIGHLIGHT.19 September 2024.

Plozasiran lessened triglyceride amounts by 80% and reduced the threat of pancreatitis in individuals along with persistent chylomicronemia, with or without a genetic prognosis.

Articles You Can Be Interested In

• Social Media
• Self-Help
• Data Science
• Privacy
• Weather Update
• World Sports
• Retail
• Logistics
• Career Advice
• Nutrition
• Customer Service
• Healthcare
• Art & Culture
• Gaming
• SEO Tips
• Green Energy
• Entrepreneurship
• Manufacturing
• Cultural Events
• Automotive